Estrogen receptor—positive breast cancer survival prediction and analysis of resistance–related genes introduction

BACKGROUND: In recent years, ER+ and HER2- breast cancer of adjuvant therapy has made great progress, including chemotherapy and endocrine therapy. We found that the responsiveness of breast cancer treatment was related to the prognosis of patients. However, reliable prognostic signatures based on E...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuai, Chen, Yuan, Fengyan, Liu, Yu, Wang, Chengchen, Wang, Jiansong, He, Hongye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555508/
https://www.ncbi.nlm.nih.gov/pubmed/34760348
http://dx.doi.org/10.7717/peerj.12202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555508/
https://www.ncbi.nlm.nih.gov/pubmed/34760348
http://dx.doi.org/10.7717/peerj.12202

Ejemplares similares